D-1137-2017 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-1137-2017 was initiated by Zydus Pharmaceuticals USA Inc on Aug 18, 2017 and is designated Class II. Reason for recall: Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets The recall status is terminated (terminated Jan 6, 2020). Affected quantity: 44800 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 20, 2017
Initiation Date
Aug 18, 2017
Termination Date
Jan 6, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
44800 bottles

Product description

Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, NDC 68382-099-06, UPC 3 6838209906 8

Reason for recall

Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets

Distribution pattern

Nationwide within United States

Code information

Lot #: Z701133, Exp 03/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1137-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1137-2017. Report a data issue: hello@regdatalab.com.